Lung volume reduction coil treatment vs usual care in patients with severe emphysema the REVOLENS randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 315, Issue 2, 2016, Pages 175-184

  Deslée, Gaëtan ^a   Mal, Hervé ^b   Dutau, Hervé ^c   Bourdin, Arnaud ^d   Vergnon, Jean Michel ^e   Pison, Christophe ^f   Kessler, Romain ^g   Jounieaux, Vincent ^h   Thiberville, Luc ⁱ   Leroy, Sylvie ^j   Marceau, Armelle ^b   Laroumagne, Sophie ^c   Mallet, Jean Pierre ^d   Dukic, Sylvain ^a   Barbe, Coralie ^a   Bulsei, Julie ^k   Jolly, Damien ^a   Durand Zaleski, Isabelle ^k   Marquette, Charles Hugo ^j  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b Groupe Hospitalier Universitaire Bichat Claude Bernard   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ JEAN MONNET   (France)

^f Domaine Universitaire   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ ROUEN UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYGEN; ALLOY; NITINOL;

ADULT; BRONCHOSCOPY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HUMAN; LUNG EMPHYSEMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NITINOL COIL; PHYSICAL CAPACITY; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY THERAPEUTIC DEVICE; REVIEW; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THORAX PAIN; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; COST BENEFIT ANALYSIS; EMPHYSEMA; LUNG RESECTION; MIDDLE AGED;

AGED; ALLOYS; BRONCHOSCOPY; COST-BENEFIT ANALYSIS; EMPHYSEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME;

EID: 84954551009     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.17821     Document Type: Review

References (30)

1. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery vs medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82(2):431-443.
2. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059-2073.
3. Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012;39 (6):1334-1342.
4. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13): 1233-1244.
5. Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial). Lancet. 2011;378(9795):997-1005.
6. Come CE, Kramer MR, Dransfield MT, et al. A randomised trial of lung sealant vs medical therapy for advanced emphysema. Eur Respir J. 2015;46(3):651-662.
7. Snell GI, Hopkins P, Westall G, et al. A feasibility and safety study of bronchoscopic thermal vapor ablation. Ann Thorac Surg. 2009;88(6):1993-1998.
8. Herth FJ, Eberhard R, Gompelmann D, et al. Bronchoscopic lung volume reduction with a dedicated coil. Ther Adv Respir Dis. 2010;4(4):225-231.
9. Deslee G, Klooster K, Hetzel M, et al. Lung volume reduction coil treatment for patients with severe emphysema. Thorax. 2014;69(11):980-986.
10. Klooster K, Ten Hacken NH, Slebos DJ. The lung volume reduction coil for the treatment of emphysema. Expert Rev Med Devices. 2014;11(5): 481-489.
11. Kontogianni K, Gerovasili V, Gompelmann D, et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures. Respiration. 2014;88(1):52-60.
12. Shah PL, Zoumot Z, Singh S, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET). Lancet Respir Med. 2013;1(3):233-240.
13. Slebos DJ, Klooster K, Ernst A, et al. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012;142(3):574-582.
14. Zoumot Z, Kemp SV, Singh S, et al. Endobronchial coils for severe emphysema are effective up to 12 months following treatment. PLoS One. 2015;10(4):e0122656.
15. Pietzsch JB, Garner A, Herth FJF. Cost-effectiveness of endobronchial valve therapy for severe emphysema. Respiration. 2014;88(5): 389-398.
16. Deslee G, Barbe C, Bourdin A, et al. Cost-effectiveness of lung volume reduction coil treatment in emphysema. Rev Mal Respir. 2012;29 (9):1157-1164.
17. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001; 345(15):1075-1083.
18. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(suppl 16):5-40.
19. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155(4):1278-1282.
20. Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration. Value Health. 2013;16(2):231-250.
21. Knottnerus JA, Bouter LM. The ethics of sample size: 2-sided testing and 1-sided thinking. J Clin Epidemiol. 2001;54(2):109-110.
22. Slebos DJ, Hartman JE, Klooster K, et al. Bronchoscopic coil treatment for patients with severe emphysema. Respiration. 2015;90(2):136-145.
23. Chandra D, Wise RA, Kulkarni HS, et al. Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest. 2012;142(6):1545-1552.
24. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-1446.
25. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
26. Jones PW. St George's Respiratory Questionnaire: MCID. COPD. 2005;2(1):75-79.
27. Mahler DA, Witek TJ Jr. The MCID of the Transition Dyspnea Index is a total score of one unit. COPD. 2005;2(1):99-103.
28. Hartman JE, Ten Hacken NH, Klooster K, et al. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J. 2012;40(5):1137-1141.
29. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2 (1):111-124.
30. Ramsey SD, Berry K, Etzioni R, et al. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003;348(21):2092-2102.